Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

22.90
Delayed Data
As of Feb 24
 -0.65 / -2.76%
Today’s Change
16.75
Today|||52-Week Range
39.99
+3.85%
Year-to-Date
Will Lannett (LCI) Continue to Surge Higher?
Feb 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close23.55
Today’s open23.35
Day’s range22.40 - 23.55
Volume583,574
Average volume (3 months)1,184,185
Market cap$851.6M
Dividend yield--
Data as of 4:01pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-70.30%
Earnings growth (this year)+0.62%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+39.14%
P/E ratioNM
Price/Sales1.57
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.09-1.49%
INSYINSYS Therapeutics I...-0.77-6.02%
INSMInsmed Inc+0.53+3.82%
CLCDCoLucid Pharmaceutic...+0.05+0.11%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.86
Annual revenue (last year)$566.1M
Annual profit (last year)$44.8M
Net profit margin7.91%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
CFO, Treasurer &
Vice President-Finance
Martin P. Galvan
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts


Search for Jobs